By Scientia Professor Louisa Jane Degenhardt

Conference Abstracts

Prestage G; Hammoud M; Bavinton B; Bourne A; Holt M; Vaccher S; Degenhardt L; Maher L; Keen P; Haire B; Grulich A; Jin F, 2019, 'ELIGIBILITY FOR AND USE OF HIV PRE-EXPOSURE PROPHYLAXIS AMONG AUSTRALIAN GAY AND BISEXUAL MEN OVER TIME', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, Vol. 95, pp. A209 - A209, http://dx.doi.org/10.1136/sextrans-2019-sti.527

Valerio H; Alavi M; Silk D; Treloar C; Milat A; Dunlop A; Holden J; Henderson C; Amin J; Read P; Degenhardt L; Dore G; Grebely J, 2019, 'Uptake of testing, linkage to care, and treatment for hepatitis C infection among people who inject drugs in Australia: The ETHOS Engage study', in JOURNAL OF HEPATOLOGY, ELSEVIER, AUSTRIA, Vienna, Vol. 70, pp. E42 - E42, presented at International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), AUSTRIA, Vienna, 10 April 2019 - 14 April 2019, http://dx.doi.org/10.1016/S0618-8278(19)30076-3

Peacock A; Roxburgh A; Sutherland R; Uporova J; Karlsson A; Gibbs D; Degenhardt L; Bruno R; Dietze PM; Lenton S; Alati R; Farrell M, 2018, 'AVAILABILITY AND USE OF NEW AND EMERGING PSYCHOACTIVE SUBSTANCES IN AUSTRALIA', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 37, pp. S57 - S58, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449495000143&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Stockings E; Campbell G; Hall WD; Nielsen S; Zagic D; Rahman R; Murnion B; Farrell M; Weier M; Degenhardt L, 2018, 'CANNABINOIDS FOR THE TREATMENT OF CHRONIC NON-CANCER PAIN: AN OVERVIEW OF THE EVIDENCE', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 37, pp. S69 - S69, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449495000171&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Prestage GP; Hammoud MA; Maher L; Degenhardt L; Bourne A; Lea T; Mackie B; Bath N; Haire BG; Batrouney C; Jin F, 2018, 'INITIATION OF ILLICIT DRUG USE IN THE FLUX COHORT OF AUSTRALIAN GAY AND BISEXUAL MEN', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 37, pp. S60 - S60

Colledge S; Peacock A; Leung J; Grebely J; Hickman M; Farrell M; Larney S; Degenhardt L, 2018, 'NON-FATAL OVERDOSE PREVALENCE AMONG PEOPLE WHO INJECT DRUGS - A MULTI-STAGE SYSTEMATIC REVIEW AND META-ANALYSIS OF RECENT EVIDENCE', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 37, pp. S23 - S23, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449495000060&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hammoud MA; Prestage GP; Bourne A; Maher L; Jin F; Haire BG; Lea T; Degenhardt L; Saxton PJ; Bath N; Mackie B; Batrouney C, 2018, 'SYMPOSIUM: THE CURRENT STATE OF DRUG USE AMONG AUSTRALIAN GAY AND BISEXUAL MEN: FACTORS ASSOCIATED WITH DRUG USE, INITIATION AND DEPENDENCE', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 37, pp. S10 - S11

Peacock A; Bruno R; Roxburgh A; Mathur A; Dietze PM; Lenton S; Alati R; Gisev N; Memedovic S; Crossin R; Scott D; Lubman DI; Smith K; Brown J; Cairns R; Jauncey M; Sutherland R; Gibbs D; Uporova J; Karlsson A; Degenhardt L; Farrell M, 2018, 'TRENDS IN FENTANYL AVAILABILITY, USE AND HARMS IN AUSTRALIA', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 37, pp. S56 - S56, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449495000141&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Gisev N; Pearson S; Larance B; Larney S; Blanch B; Degenhardt L, 2018, 'The safety of fentanyl patch initiation in Australian clinical practice: A population-based study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 27, pp. 437 - 437, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000441893804049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Jacka B; Larney S; Hoj S; Degenhardt L; Krajden M; Janjua N; Grebely J; Bruneau J, 2018, 'Estimating the number of people who inject drugs and the coverage of harm reduction services in Canada', in JOURNAL OF VIRAL HEPATITIS, WILEY, CANADA, Toronto, Vol. 25, pp. 131 - 131, presented at 16th International Symposium on Viral Hepatitis and Liver Diseases (ISVHLD), CANADA, Toronto, 14 June 2018 - 17 June 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000435101000220&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Campbell G; Nielsen S; Lintzeris N; Bruno R; Peacock A; Chan GCK; Larance B; Cohen M; Farrell M; Hall WD; Degenhardt L, 2017, 'CANNABIS USE AMONG PEOPLE PRESCRIBED OPIOIDS FOR CHRONIC NON-CANCER PAIN: OBSERVATIONS FROM THE POINT COHORT', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 36, pp. 24 - 25, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000424000500059&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Nielsen S; Larance B; Lintzeris N; Holliday S; Dunlop AJ; Haber PS; Murnion BP; Silsbury C; Johnson J; Demirkol A; Ling S; Sadler C; Phung N; Bruno R; Hardy M; Brown AL; Houseman J; Degenhardt L, 2017, 'TREATING OVER THE COUNTER CODEINE DEPENDENCE: TWO YEAR OUTCOMES FROM A COHORT OF PHARMACEUTICAL OPIOID DEPENDENT PEOPLE', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 36, pp. 13 - 14, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000424000500030&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lea T; Hammoud MA; Jin F; Degenhardt L; Grierson J; Mackie B; Pastorelli M; Batrouney C; Bath N; Bradley J; Maher L; Prestage GP, 2016, 'ATTITUDES TOWARDS ILLICIT DRUG USE AMONG GAY AND BISEXUAL MEN IN AUSTRALIA: EVIDENCE FOR NORMALISATION?', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 49 - 49, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500132&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Campbell G; Bruno R; Lintzeris N; Cohen M; Nielsen S; Hall W; Larance B; Mattick RP; Blyth F; Farrell M; Degenhardt L, 2016, 'DEFINING PROBLEMATIC PHARMACEUTICAL OPIOID USE AMONG PEOPLE PRESCRIBED OPIOIDS FOR CHRONIC NON-CANCER PAIN: DO DIFFERENT MEASURES IDENTIFY THE SAME PATIENTS?', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 30 - 30, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500082&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Larney S; Grebely J; Degenhardt L; Amin J; Law M; Alavi M; Dore GJ; Law M, 2016, 'EXPOSURE TO OPIOID SUBSTITUTION THERAPY FOLLOWING HEPATITIS C NOTIFICATION: IMPLICATIONS FOR PROVISION OF ANTIVIRAL THERAPIES IN DRUG TREATMENT SETTINGS', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 48 - 48

Nielsen S; Peacock A; Lintzeris N; Bruno R; Larance B; Degenhardt L, 2016, 'OVERDOSE KNOWLEDGE AND PERCEPTIONS OF TAKE-HOME NALOXONE FOR PATIENTS WITH CHRONIC NON-CANCER PAIN', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 56 - 57, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500153&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Prestage GP; Jin F; Hammoud MA; Degenhardt L; Lea T; Grierson J; Mackie B; Pastorelli M; Batrouney C; Bath N; Bradley J; Maher L, 2016, 'PARTY DRUG USE WITHIN GAY COMMUNITY NETWORKS IN AN ONLINE COHORT OF GAY AND BISEXUAL MEN', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 62 - 62, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500168&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Moore T; O'Donnell C; Degenhardt L; Campbell G; Nielsen S; Larance B, 2016, 'PHYSICAL HEALTH AND UTILISATION OF ALCOHOL AND OTHER DRUG TREATMENT AMONG A SAMPLE OF CHRONIC NON-CANCER PAIN PATIENTS DEPENDENT ON THEIR OPIOID MEDICATION', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 55 - 56, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500150&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Larance B; Ali R; Farrell M; Peacock A; Bruno R; Lintzeris N; Dobbins T; Degenhardt L, 2016, 'THE IMPACT OF REFORMULATED OXYCONTIN (R) IN AUSTRALIA: KEY FINDINGS FROM THE NATIONAL OPIOID MEDICATIONS ABUSE DETERRENCE', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 47 - 47, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500128&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Gisev N; Pearson S-A; Blanch B; Larance B; Dobbins T; Larney S; Degenhardt L, 2016, 'Initiation Of Strong Prescription Opioids In Australia: Cohort Characteristics And Factors Associated With The Type Of Opioid Initiated', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY-BLACKWELL, Vol. 25, pp. 212 - 213, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000385483501355&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Larance B; Cama E; Bruno R; Farrell M; Ali R; Lintzeris N; Peacock A; Kihas I; Hordern T; White N; Degenhardt L, 2014, 'PATTERNS OF OPIOID CONSUMPTION IN A COHORT OF PEOPLE WHO TAMPER WITH PHARMACEUTICAL OPIOIDS: BASELINE FINDINGS FROM THE NATIONAL OPIOID MEDICATION ABUSE DETERRENCE (NOMAD) STUDY', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, Vol. 33, pp. 38 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344914800111&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Reports

Chrzanowska A; Man N; Sutherland R; Degenhardt L; Peacock A, 2024, Trends in overdose and other drug-induced deaths in Australia, 2003-2022, NDARC, Sydney, http://dx.doi.org/10.26190/unsworks/30158

Asare-Doku W; Stolk S; Peacock AMY; Shakeshaft A; Waller E; Nathan S; Economidis G; Ravulo J; Meo-Sewabu L; D'Este C; Thapa P; Abbott T; Satour T; Tulele L; Wilson K; Doran C; Mhey-Rivas T; Macpherson G; Lynch M; Taylor S; Santo T; Graham D; Baillie G; Tran A; Aiken A; Harwood E; Turner A; Reeve R; Degenhardt L; Farrell M; Santo Jr T, 2023, Monitoring and Evaluation of the Kava Pilot Program, National Drug and Alcohol Research Centre, UNSW, Sydney, https://www.odc.gov.au/resources/publications/monitoring-and-evaluation-kava-pilot-program

Sutherland R; Karlsson A; King C; Uporova J; Chandrasena U; Jones F; Gibbs D; Price O; Dietze P; Lenton S; Salom C; Bruno R; Wilson J; Grigg J; Daly C; Thomas N; Radke S; Stafford L; Degenhardt L; Farrell M; Peacock A, 2023, Australian Drug Trends 2023: Key Findings from the National Ecstasy and Related Drugs Reporting System (EDRS) Interviews., NDARC, Sydney, http://dx.doi.org/10.26190/1qta-pe36, https://ndarc.med.unsw.edu.au/resource/australian-drug-trends-2023-key-findings-national-ecstasy-and-related-drugs-reporting

Sutherland R; Uporova J; King C; Chandrasena U; Karlsson A; Jones F; Gibbs D; Price O; Dietze P; Lenton S; Salom C; Bruno R; Wilson J; Agramunt S; Daly C; Thomas N; Radke S; Stafford L; Degenhardt L; Farrell M; Peacock A, 2023, Australian Drug Trends 2023: Key Findings from the National Illicit Drug Reporting System (IDRS) Interviews., NDARC, Sydney, http://dx.doi.org/10.26190/1tj1-8454, https://ndarc.med.unsw.edu.au/resource/australian-drug-trends-2023-key-findings-national-illicit-drug-reporting-system-idrs

Shahbazi J; Farrell M; Byrne J; Ali R; Puszka B; Lim XQ; Cook J; Weiss R; Rodgers C; Dunlop A; Lintzeris N; Nielsen S; Grebely J; Zahra E; Degenhardt L; Byrne M, 2023, Considerations for delivering extended-release buprenorphine for opioid dependence in Australia: Preliminary lessons from the Community Long-Acting Buprenorphine (CoLAB) trial, NATIONAL DRUG AND ALCOHOL RESEARCH CENTRE, UNIVERSITY OF NEW SOUTH WALES, SYDNEY, 2020, RANDWICK, 355, http://dx.doi.org/10.26190/zemp-dx93

Yuen WS; Walsberger S; Sutherland R; Price K; Degenhardt L; Reakes K; Cerio R; Woolley N; King C; Spencer E; Vaughan M; Watson L; Miller N; Clay S; Symes E; Peacock A, 2023, Alcohol-related behaviours, beliefs, and knowledge regarding cancer risk related to alcohol in the New South Wales LGBTQ+ community, National Drug and Alcohol Research Centre, Sydney, 354, http://dx.doi.org/10.26190/5mty-d787, https://ndarc.med.unsw.edu.au/resource/alcohol-related-behaviours-beliefs-and-knowledge-regarding-cancer-risk-related-alcohol-new

Chidwick K; Bharat C; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Real-world dosing intervals of long-acting buprenorphine for opioid agonist treatment., UNSW Sydney, Sydney, 345, http://dx.doi.org/10.26190/ayet-f348, https://ndarc.med.unsw.edu.au/resource/real-world-dosing-intervals-long-acting-buprenorphine-opioid-agonist-treatment

Bharat C; Chidwick K; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in New South Wales, 2013-2022, UNSW Sydney, Sydney, 347, http://dx.doi.org/10.26190/rzmn-a864, https://ndarc.med.unsw.edu.au/resource/nsw-trends-use-opioid-agonist-treatment-australia-2013-2022

Bharat C; Chidwick K; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in Queensland, 2013-2022, UNSW Sydney, Sydney, 349, http://dx.doi.org/10.26190/ybm1-3f83, https://ndarc.med.unsw.edu.au/resource/qld-trends-use-opioid-agonist-treatment-australia-2013-2022

Chidwick K; Gisev N; Degenhardt L; Farrell M; Bharat C, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in South Australia, 2013-2022, UNSW Sydney, Sydney, 350, http://dx.doi.org/10.26190/y21d-yd24, https://ndarc.med.unsw.edu.au/resource/sa-trends-use-opioid-agonist-treatment-australia-2013-2022

Chidwick K; Gisev N; Degenhardt L; Farrell M; Bharat C, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in Tasmania, 2013-2022, UNSW Sydney, Sydney, 351, http://dx.doi.org/10.26190/q6zj-fx75, https://ndarc.med.unsw.edu.au/resource/tas-trends-use-opioid-agonist-treatment-australia-2013-2022

Bharat C; Chidwick K; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in the Australian Capital Territory, 2013-2022, UNSW Sydney, Sydney, 346, http://dx.doi.org/10.26190/16m9-6z16, https://ndarc.med.unsw.edu.au/resource/ndarc-technical-reports-345-353

Bharat C; Chidwick K; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in the Northern Territory, 2013-2022, UNSW Sydney, Sydney, 348, http://dx.doi.org/10.26190/mt8r-kd57, https://ndarc.med.unsw.edu.au/resource/nt-trends-use-opioid-agonist-treatment-australia-2013-2022

Chidwick K; Gisev N; Degenhardt L; Farrell M; Bharat C, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in Victoria, 2013-2022, UNSW Sydney, Sydney, 352, http://dx.doi.org/10.26190/gjpp-py45, https://ndarc.med.unsw.edu.au/resource/vic-trends-use-opioid-agonist-treatment-australia-2013-2022

Chidwick K; Gisev N; Degenhardt L; Farrell M; Bharat C, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in Western Australia, 2013-2022, UNSW Sydney, Sydney, 353, http://dx.doi.org/10.26190/ftbz-w461, https://ndarc.med.unsw.edu.au/resource/wa-trends-use-opioid-agonist-treatment-australia-2013-2022

Chrzanowska A; Man N; Akhurst J; Sutherland R; Degenhardt L; Peacock A, 2023, Trends in Overdose and Other Drug-Induced Deaths in Australia, 2002-2021, NDARC, Sydney, http://dx.doi.org/10.26190/m2gs-z325, https://ndarc.med.unsw.edu.au/resource-analytics/trends-drug-induced-deaths-australia-2002-2021

Asare-Doku W; Macdonald C; Ottaviano S; Degenhardt L; Farrell M, 2023, Review of interventions to treat drug use disorders among girls and women in the criminal justice system in low- and middle-income countries, https://www.unodc.org/documents/commissions/CND/CND_Sessions/CND_66/ECN72023_CRP10_2304065E.pdf

McKetin R; Thapa P; Uthurralt N; Bo A; Degenhardt L; Farrell M; Mounteney J; Griffiths P; Degan T, 2023, An Overview Of The Evidence For Substance Use Interventions, NDARC, Sydney, http://dx.doi.org/10.26190/yb4b-1c31, https://ndarc.med.unsw.edu.au/resource/overview-evidence-substance-use-interventions

Clay S; Yuen WS; Spencer E; Peacock A; Walsberger S; Price K; Sutherland R; Degenhardt L; Popovski H, 2023, Perceptions of risky alcohol use, health risks related to alcohol, and alcohol-related help-seeking in the LGBTQ+ community, https://ndarc.med.unsw.edu.au/project/perceptions-risky-alcohol-use-health-risks-related-alcohol-and-alcohol-related-help-seeking

Brothers T; Degenhardt L, 2022, Time periods of altered risk for severe injection drug use-associated skin and soft-tissue infections: protocol for a self-controlled case series in New South Wales, Australia, 2001-2018, UCL Press, http://dx.doi.org/10.14324/000.rp.10157481, http://dx.doi.org/10.14324/000.rp.10157481

Chrzanowska A; Man N; Akhurst J; Sutherland R; Degenhardt L; Peacock A, 2022, Trends in drug-related hospitalisations in Australia, 1999-2021., NDARC, Sydney, http://dx.doi.org/10.26190/wrsv-3b78

Sutherland R; Karlsson A; King C; Jones F; Uporova J; Price O; Gibbs D; Bruno R; Dietze P; Lenton S; Salom C; Grigg J; Wilson Y; Wilson J; Daly C; Thomas N; Juckel J; Degenhardt L; Farrell M; Peacock A, 2022, Australian Drug Trends 2022: Key Findings from the National Ecstasy and Related Drugs Reporting System (EDRS) Interviews., NDARC, Sydney, http://dx.doi.org/10.26190/hbqt-9d09

Sutherland R; Karlsson A; King C; Jones F; Uporova J; Price O; Gibbs D; Bruno R; Dietze P; Lenton S; Salom C; Grigg J; Wilson Y; Wilson J; Daly C; Thomas N; Juckel J; Agramunt S; Que Noy W; Degenhardt L; Farrell M; Peacock A, 2022, Australian Drug Trends 2022: Key Findings from the National Illicit Drug Reporting System (IDRS) Interviews., NDARC, Sydney, http://dx.doi.org/10.26190/5czp-af24

Man N; Sisson S; McKetin R; Chrzanowska A; Bruno R; Dietze P; Price O; Degenhardt L; Gibbs D; Salom C; Peacock A, 2022, Trends in methamphetamine use, markets and harms in Australia, 2003-2019, NDARC, Sydney, http://dx.doi.org/10.26190/ad59-k695

Chrzanowska A; Man N; Sutherland R; Degenhardt L; Peacock A, 2022, Trends in overdose and other drug-induced deaths in Australia, 1997-2020, NDARC, Sydney, http://dx.doi.org/10.26190/ke9y-4731

Chrzanowska A; Man N; Sutherland R; Degenhardt L; Peacock A, 2021, Trends in drug-related hospitalisations in Australia, 1999-2020, NDARC, Sydney, http://dx.doi.org/10.26190/xzey-zb70

Sutherland R; Uporova J; Karlsson A; Price O; Chandrasena U; Swanton R; Gibbs D; Dietze P; Lenton S; Salom C; Grigg J; Wilson Y; Eddy S; Hall C; Daly C; Thomas N; Juckel J; Degenhardt L; Farrell M; Peacock A, 2021, Australian Drug Trends 2021: Key Findings from the National Ecstasy and related Drug Reporting System (EDRS) Interviews, NDARC, Sydney, http://dx.doi.org/10.26190/t6sh-g213

Sutherland R; Uporova J; Peacock A; Udesha C; Price O; Karlsson A; Gibbs D; Swanton R; Lenton S; Woods E; Farrell M; Bruno R; Dietze P; Salom C; Thomas N; Daly C; Juckel J; Agramunt S; Wilson Y; Degenhardt L; Moon C, 2021, Australian Drug Trends 2021: Key Findings from the National Illicit Drug Reporting System (IDRS) Interviews, NDARC, Sydney, http://dx.doi.org/10.26190/4p6r-jq88

Sutherland R; Baillie G; Peacock A; Hammoud M; Memedovic S; Barratt M; Bruno R; Dietze P; Ezard N; Salom C; Degenhardt L; Hughes C, 2021, Key findings from the ‘Australians’ Drug Use: Adapting to Pandemic Threats (ADAPT)’ Study Wave 4., NDARC, Sydney, http://dx.doi.org/10.26190/n5wf-2x04

Back to profile page